Working… Menu

Evaluating and Comparing the Safety and Efficiency of ASC09/Ritonavir and Lopinavir/Ritonavir for Novel Coronavirus Infection

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT04261907
Recruitment Status : Not yet recruiting
First Posted : February 10, 2020
Last Update Posted : February 10, 2020
Ascletis Pharmaceuticals Co., Ltd.
Information provided by (Responsible Party):
First Affiliated Hospital of Zhejiang University

No Study Results Posted on for this Study
Recruitment Status : Not yet recruiting
Estimated Primary Completion Date : May 31, 2020
Estimated Study Completion Date : June 30, 2020